Airflow Limitation in Cardiac Diseases in Europe (the ALICE study). - ALICE

GlaxoSmithKline0 个研究点目标入组 400 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•1. Subjects aged >=40 years;
•2. Current or former smokers with >=10 pack years;
•3. Subjects attending outpatient cardiac clinic (or equivalent) fulfilling any of the following criteria:
•a. Documented history of an Ischemic event,
•b. Current diagnosis of stable IHD (including history of acute Myocardial Infarction'(MI) and angina pectoris) as diagnosed in accordance with ESC guidelines
•c. Receiving regular therapy for IHD for >1yr,
•4. Subjects willing and able to sign study consent form.

•1. Subjects for whom spirometry is contraindicated (e.g. with detached retina, active
•tuberculosis, last trimester of pregnancy, resting pulse >120 etc);
•2. Subjects with recent surgery or MI (within 1 month); lower respiratory tract infection
•or pneumothorax (within 2 months); or stroke (within 12 months);
•3. Subjects with a pre-existing condition which, in the opinion of the investigator, would
•compromise the safety of the subject in this study.

发起方